Search research articles
Contact Us
Filters
Showing results (51-60 of 384) with videos related to
Page
of 39
Sort By:
Current Research in Immunology
|
January 30, 2023
Smad7 as a positive regulator of intestinal inflammatory diseases
Giovanni Monteleone, Federica Laudisi, Carmine Stolfi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2021
Reply
Emma Calabrese, Francesca Zorzi, Giovanni Monteleone
Annals of Thoracic Medicine
|
May 20, 2024
Endobronchial angioleiomyoma: Diagnostic difficulties of a rare lung neoplasm
Mafalda Orlando, Maurizio Alimandi, Giovanni Monteleone
Seminars in Immunopathology
|
August 10, 2013
Aryl hydrocarbon receptor and colitis
Ivan Monteleone, Francesco Pallone, Giovanni Monteleone
Cytokine & Growth Factor Reviews
|
July 8, 2010
Interleukin-25: a two-edged sword in the control of immune-inflammatory responses
Giovanni Monteleone, Francesco Pallone, Thomas T Macdonald
Expert Review of Clinical Immunology
|
August 6, 2016
Sphingosine-1-phosphate receptor: a novel therapeutic target in ulcerative colitis
Roberta Izzo, Michele M Figliuzzi, Giovanni Monteleone
Trends in Pharmacological Sciences
|
July 21, 2009
Interleukin-21 as a new therapeutic target for immune-mediated diseases
Giovanni Monteleone, Francesco Pallone, Thomas T Macdonald
Biochemical Society Transactions
|
July 27, 2011
The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease
Thomas T MacDonald, Iona Bell, Giovanni Monteleone
Journal of Crohn'S & Colitis
|
March 24, 2026
Dysplasia in inflammatory bowel disease pseudopolyps
Elena De Cristofaro, Irene Marafini, Giovanni Monteleone
Trends in Immunology
|
September 15, 2004
Smad7 in TGF-beta-mediated negative regulation of gut inflammation
Giovanni Monteleone, Francesco Pallone, Thomas T MacDonald
Page
of 39
Search research articles
Search
Showing results (51-60 of 384) with videos related to
Sort By:
Page
of 39
Current Research in Immunology
|
January 30, 2023
Smad7 as a positive regulator of intestinal inflammatory diseases
Giovanni Monteleone, Federica Laudisi, Carmine Stolfi
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2021
Reply
Emma Calabrese, Francesca Zorzi, Giovanni Monteleone
Annals of Thoracic Medicine
|
May 20, 2024
Endobronchial angioleiomyoma: Diagnostic difficulties of a rare lung neoplasm
Mafalda Orlando, Maurizio Alimandi, Giovanni Monteleone
Seminars in Immunopathology
|
August 10, 2013
Aryl hydrocarbon receptor and colitis
Ivan Monteleone, Francesco Pallone, Giovanni Monteleone
Cytokine & Growth Factor Reviews
|
July 8, 2010
Interleukin-25: a two-edged sword in the control of immune-inflammatory responses
Giovanni Monteleone, Francesco Pallone, Thomas T Macdonald
Expert Review of Clinical Immunology
|
August 6, 2016
Sphingosine-1-phosphate receptor: a novel therapeutic target in ulcerative colitis
Roberta Izzo, Michele M Figliuzzi, Giovanni Monteleone
Trends in Pharmacological Sciences
|
July 21, 2009
Interleukin-21 as a new therapeutic target for immune-mediated diseases
Giovanni Monteleone, Francesco Pallone, Thomas T Macdonald
Biochemical Society Transactions
|
July 27, 2011
The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease
Thomas T MacDonald, Iona Bell, Giovanni Monteleone
Journal of Crohn'S & Colitis
|
March 24, 2026
Dysplasia in inflammatory bowel disease pseudopolyps
Elena De Cristofaro, Irene Marafini, Giovanni Monteleone
Trends in Immunology
|
September 15, 2004
Smad7 in TGF-beta-mediated negative regulation of gut inflammation
Giovanni Monteleone, Francesco Pallone, Thomas T MacDonald
Page
of 39